Page 700 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 700

656        SectioN iii    RepRoductive  ` REPRODUCTIVE—PHARmACOlOgy                                                                                              RepRoductive  ` REPRODUCTIVE—PHARmACOlOgy





               Goserelin, leuprolide
                mECHANISm            GnRH analogs. When used in pulsatile      Leuprolide can be used in lieu of GnRH.
                                       fashion act as GnRH agonists. When used
                                       in continuous fashion first transiently act as
                                       GnRH agonists (tumor flare), but subsequently
                                       act as GnRH antagonists (downregulate
                                       GnRH receptor in pituitary Ž  FSH and
                                        LH).
                ClINICAl USE         Uterine fibroids, endometriosis, precocious
                                       puberty, prostate cancer, infertility.

                ADVERSE EFFECTS      Hypogonadism,  libido, erectile dysfunction,
                                      nausea, vomiting.



               Degarelix
                mECHANISm            GnRH antagonist. No start-up flare.
                ClINICAl USE         Prostate cancer.
                ADVERSE EFFECTS      Hot flashes, liver toxicity.



               Estrogens             Ethinyl estradiol, DES, mestranol.
                mECHANISm            Bind estrogen receptors.
                ClINICAl USE         Hypogonadism or ovarian failure, menstrual abnormalities (combined OCPs), hormone
                                       replacement therapy in postmenopausal women.
                ADVERSE EFFECTS       risk of endometrial cancer (when given without progesterone), bleeding in postmenopausal
                                       women, clear cell adenocarcinoma of vagina in females exposed to DES in utero,  risk of
                                       thrombi. Contraindications—ER ⊕ breast cancer, history of DVTs, tobacco use in women > 35
                                      years old.


               Selective estrogen receptor modulators

                Clomiphene           Antagonist at estrogen receptors in hypothalamus. Prevents normal feedback inhibition and
                                        release of LH and FSH from pituitary, which stimulates ovulation. Used to treat infertility due
                                       to anovulation (eg, PCOS). May cause hot flashes, ovarian enlargement, multiple simultaneous
                                       pregnancies, visual disturbances.
                Tamoxifen            Antagonist at breast; agonist at bone, uterus;  risk of thromboembolic events (especially with
                                       smoking) and endometrial cancer. Used to treat and prevent recurrence of ER/PR ⊕ breast
                                       cancer.
                Raloxifene           Antagonist at breast, uterus; agonist at bone;  risk of thromboembolic events (especially with
                                       smoking) but no increased risk of endometrial cancer (vs tamoxifen); used primarily to treat
                                       osteoporosis.



               Aromatase inhibitors  Anastrozole, letrozole, exemestane.
                mECHANISm            Inhibit peripheral conversion of androgens to estrogen.
                ClINICAl USE         ER ⊕ breast cancer in postmenopausal women.











          FAS1_2019_15-Repro.indd   656                                                                                 11/7/19   5:52 PM
   695   696   697   698   699   700   701   702   703   704   705